News & Press


We are committed to developing cutting-edge treatments for gastrointestinal diseases. Our management team, with years of relevant clinical, regulatory and commercial experience, is supported by an outstanding medical advisory board comprised of foremost researchers in lactose intolerance and gastrointestinal diseases.

Together we are committed to the vision of reducing the debilitating impact of lactose intolerance, in addition to other gastrointestinal diseases, on patients globally.

Featuring Recent Posts WordPress Widget development by YD